ArticleEuropean journal of medical research2024

Network pharmacology and molecular docking analysis on Shenfu Qiangxin indicate mTOR is a potential target to treat heart failure.

Peilin Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.